| GTO ID |
GTD0331 |
| Accession |
E-MTAB-11315
|
| Gene therapy-related clinical trial |
GTC2404 |
| Altered gene |
S |
| Gene xrefs |
Gene ID:
1489668
|
| Treatment |
ARCT-021(ARCT COVID-19 vaccine) |
| Control |
Click to openARCT.101.1102.Day3_07;ARCT.101.1107.Day3_12;ARCT.101.2103.Day3_09;ARCT.101.2106.Day3_06;ARCT.101.2108.Day3_03;ARCT.101.2111.Day3_03;ARCT.101.3101.Day3_03;ARCT.101.3104.Day3_12;ARCT.101.4103.Day3_11;ARCT.101.4107.Day3_03;ARCT.101.4117.Day3_01;ARCT.101.4119.Day3_07;ARCT.101.5104.Day3_08;ARCT.101.5108.Day3_12;ARCT.101.5109.Day3_01;ARCT.101.5116.Day3_08;ARCT.101.6103.Day3_11;ARCT.101.6108.Day3_07;ARCT.101.6110.Day3_03;ARCT.101.6111.Day3_07;ARCT.101.7103.Day3_05;ARCT.101.7105.Day3_11;ARCT.101.7108.Day3_03;ARCT.101.7115.Day3_07;ARCT.101.8105.Day3_05;ARCT.101.8106.Day3_09;ARCT.101.8109.Day3_09;ARCT.101.8112.Day3_09 |
| Case |
Click to openARCT.101.6101.Day3_03;ARCT.101.6102.Day3_07;ARCT.101.6104.Day3_03;ARCT.101.6105.Day3_07;ARCT.101.6106.Day3_11;ARCT.101.6107.Day3_03;ARCT.101.6109.Day3_11;ARCT.101.6112.Day3_11;ARCT.101.6113.Day3_03;ARCT.101.6114.Day3_07;ARCT.101.6115.Day3_11;ARCT.101.6116.Day3_03;ARCT.101.8101.Day3_01;ARCT.101.8102.Day3_05;ARCT.101.8103.Day3_09;ARCT.101.8104.Day3_01;ARCT.101.8107.Day3_01;ARCT.101.8108.Day3_05;ARCT.101.8110.Day3_01;ARCT.101.8111.Day3_05;ARCT.101.8113.Day3_01;ARCT.101.8114.Day3_05;ARCT.101.8115.Day3_09;ARCT.101.8116.Day3_01 |
| Disease |
COVID-19 |
| Disease information |
Disease group: Infection
Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2.
Xref:
DO:0080600
|
| Organism |
Homo sapiens |
| Tissue/Cell type |
blood |
| Characteristics |
Day3;3 microgram |
| Strategy |
Microarray |
| Platform |
A-MTAB-668 |